INDEX
TO
VOLUME
105
The General Index covers original articles, reviews and the epitome.
The following names are printed in SMALL
CAPITALS
: Authors of original articles and
of books reviewed. Names of authorities referred to in the text are in ordinary type.
(R.) indicates a Review;the title of the book reviewed is followed by the author's name.
(E.) indicatesthe Epitomesection; the title of the epitome is followed by the author's
name.
The names of authors referred to in the Epitome are listed in Part II.
PART 1.—GENERAL INDEX
Acetyipromazine and promazine, trial of, 260
ACKNER, B., and PAMPIGLIONE, G., Observations
during
ADAM50N,
light barbiturate
J.
D. , The
narcosis,
clinical
on arousal
following
Megimide
(Bemegride)
788
use
of
stilboestrol
for
suppression
of
sexual
behaviour
of
chronically ill male psychiatric patients, 762
Adrenaline. See Epinephrine
Adrenochrome and schizophrenia, further studies, 653, 663
(E.), 575
,,
potentiation
of
effects
of,
by
phenobarbitone,
51
Akinesis with mutism (stupor), an investigation and survey of 27 cases of, by S. Smith, 1088
Alcohol and barbiturate
(E.), 575
intoxications, partial equivalence of chronic. Fraser, H. F., et a!.
Alcoholics, addictive, liver damage in, by W. W. Kay, K. C. Murfitt and M. M. Glatt, 748
Alcoholism
and behaviour
,,
auditory
,,
disutfiram
therapy,
67
hallucinations
and
in.
citrated
Victor,
M.,
calcium
and
Hope,
carbimide
in,
J.
M.
(E.),
559
476
Amobarbital (amylobarbitone) and methamphetamine,
attention, by E. Callaway, III, 382
the influence of, on the focus of
Amygdala, investigation of the primate. Frost, L. L., et a!. (E.), 571
,,
syndrome
in
the
cat,
effect
of
hypothalamic
lesions
on
the.
Kling,
A.,
and
Hutt,
P.J.(E.),
522
Amygdalae
and behavior,
the. Masserman,
J. H., et a!. (E.), 518
Amygdaloid complex of anesthetized animals, localization within the. Wood, C. D., et a!.
(E.),
571
Amygdaloid
and septal lesions, effects of, on emotional
behavior
and conditioned
avoidance
responses in the rat. King, F. A. (E.), 555
Anaemia, megaloblastic, and anticonvulsants, 819
Anticonvulsant drug, a-(p-aminophenyl)-a-ethyl glutarimide, preparation 16038 (Ciba), a
clinical trial with a new, by W. Fabisch, 448
Anticonvulsants and megaloblastic anaemia, by J. Johnson, 819
Anti-depressant drug, preliminary study of a new (SKF5). Friedhoff, A. J., et a!. (E.), 560
Apperception test, a children's, by D. Walton, 359
Apraxia, the nature of. Denny-Brown, D. (E.), 555
ASHBY, W. Ross,
BASSETF, M. , COLLINS, G. H., and TAYLOR, A. L. , A clinical
trial of Covatin
on elderly patients with anxiety and restlessness, 504
Attention, forms of, influence of amylobarbitone
and methamphetamine
on, 382
Atropine-like
poisoning due to tranquilizing
agents. Mahrer, P. R., et a!. (E.), 520
AUNGLE,
P. G. , The
care
and
treatment
of psychopathic
offenders
in Norway,
Sweden
and
Denmark, 428
Azacyclonal
hydrochloride
(Frenquel),
a study
of the
C. F. Lascellesand L. J. Levene, 247
,,
(Frenquel)
,,
an
in
chronic
investigation
schizophrenia.
into
the
use
of,
Hollander,
effects
of,
on
the
L.,
in chronic
et
a!.
hallucinations
(E.),
schizophrenia,
526
ofchronic
schizophrenic
patients, by M. A. Hargreaves, 210
BAKER, A. A. , and BARKER, J. C. , Deaths
,,
and
THORPE,
J.
G.,
Trials
associated
and
BAKER, J. P., A controlled
trial of ethylcrotonylurea,
BARKER, J. C. , and BAKER, A. A., Deaths associated
,‘
and
MAY,
(Brevidil
A.,
Prolonged
with electroplexy,
tribulations,
apnoea
“¿E―),
496
1129
339
1082
852
with electroplexy,
following
E.C.T.
339
modified
by
suxethonium
by
1130
INDEX
[email protected], A. A., and M@ainy,E., Susceptibility to methylpentynol, 957
,,
,,
‘¿,
The
temporal
reliability
of
the
Maudsley
Personality
Inventory, 238
Barbiturate narcosis, observations on arousal following Megimide, 788
,,
potentiation
of
effects
of
alcohol
by,
51
Barbiturates, influence of amylobarbitone on attention, 382
BAS (Benzyl analog of serotonin), clinical evaluation of. Rudy, L. H., et a!. (E.), 557
Basal ganglia in gargoylism, 1070
,,
,‘
operations,
implications
of
a
five-year
study
of,
700.
Cooper,
I.
S.,
and
Bravo, G. J. (E.), 572
B4@sssrr,M., and Cou.mis, 0. H., The effect of E.C.T. on initiative, 863
,,
COLLINS,
G.
H.,
TAYLOR,
A.
L.,
and
Asusy,
W.
Ross,
A
clinical
trial
of
Covatin
on elderly patients with anxiety and restlessness, 504
Bn@rrse,M. K., and H@AsMAN,
M. A., Adrenal lipoids as seen post mortem in schizophrenia,
979
Bemegride. See Megimide
Benactyzine, a new antiphobic agent. Feinblatt, T. M., et a!. (E.), 530
BERin@io, J. R., Kiss,
G. D., and Wnmmtws,
W., Effects of certain
vitamins
and histamines
on the LSD psychosis, 1095
Biology, the Physical Foundation of, by W. M. Elsasser, review by W. Ross Ashby (R.), 265
Birth duration and childhood anxieties, an investigation of relationship between, by B. J.
Bolin, 1045
BLACK, D. A., W@sH,
G. P., and WALTON, D., The relative
efficacy
of “¿Vespral―
and chlor
promazine in the treatment of a group of chronic schizophrenic patients,
199
,,
and
WaLroN,
D.,
The
predictive
validity
of
a
psychological
test
of
brain
damage, 807
,,
WALTON,
D.,
and
MATHER,
M.,
The
validity
of
the
Meehi
M.M.P.I.
psychotic
scale in the diagnosis of schizophrenia, 869
Bi@ia, R. A., Saii@*.it,S., and Kit.@wiscxi, J. A., Methyiphenidate (Ritalin), 1032
Bi.awm, D. B., and WECKOWICZ,
T. E., Sizeconstancy and abstract thinking in schizophrenic
patients, 909
Blood plasma from psychotic patients, effect of, upon performance of trained rats. Winter
C. A., and Flataker, L. (E.), 526
,,
pressure
and
BOCKNER, S., Gilles
emotion,
840
de Ia Tourette's
disease,
1078
BOLIN,B. J., An investigation of relationship between birth duration and childhood anxieties,
1045
BOUNO,
L., et a!., Changes
in catechol
amine
response
to successive
E.C.T.s,
821
BOszöR.M@NY1,
Z., and NAGY, T., Observations on the psychotogenic effect of N-N-diethyl
tryptamine,
171
Brain damage. See a!so under Head Injury
,,
,,
the
predictive
validity
of
a
psychological
test
of,
by
D.
Walton
and
D.
A.
Black, 807
BRANDON, M. W. G., Kinwr@,
BRENGELMANN, J. C., Abnormal
,,
Expressive
‘¿,
PARE,
B. H., and Wiw@is,
C. E., Microcephaly,
721
and personality
correlates
of certainty,
142
movement
C.
M.
B.,
and
and
learning,
SANDLER,
81
M.,
Effects
of
5-hydroxytryptophan
on
schizophrenia, 770
BRIERLEY, J. B., and CoRsELus,
J. A. N., Observations
on the pathology
ofinsidious
dementia
following head injury, 714
BROOKS, E. M., National
statistics
in the epidemiology
BROWNE, M. W., and DRANSFIELD, G. A., A clinical
of mental illness,
trial of deserpidine
893
and reserpine
in the
treatment of the chronic schizophrenic, 1112
CAINE, T. M., and
Fouws,
G. A., The assessment
ofsome
symptoms
and signs
of depression
in women, 182
,,
,,
,,
Symptom
clusters
and
personality
types
among
psycho
neurotic men compared with women, 469
CALLAWAY, E., The influence
ofamobarbital
and methamphetamine
on the focus
of attention,
382
Carbon monoxide poisoning, EEG findings in. (E.), 531
Catatonia, experimental, 4
Catechol amine response to successive E.C.T., changes in, by L. L. Havens, Cf a!., 821
CAWTE, J. E., HAVENS, L. L., and
HARTY, J. F., Cutis
anserina,
833
Central nervous system, effect o :prolonged treatment with tranquilizing drugs upon two
enzymes of the, Ashby, W. R. (E.), 569
Cerebral gray matter, diffuse traumatic degeneration of the. Denst, J., et a!. (E.), 563
,,
thrombosis,
the
use
of
anti-coagulants
in.
Fisher,
C.
M.
(E.),
570
Cerebrospinal fluid free cholesterol as index ofactivity ofmultiple sclerosis and allied diseases.
Poser, C. M., and Curran, G. L. (E.), 525
INDEX
1131
Cerebrospinal fluid neuraminic acid deficiency in schizophrenia. Bogoch, S. (E.), 525
Ceruloplasmin, some aspects ofthe relation of, to Wilson's disease. Scheinberg, I. H. (E.), 568
,,
transferrin
Chemotherapy
and
of mental
tryptophan
disease,
in
schizophrenia.
Frohman,
some pharmacologic
C.
correlations
E.
(E.),
524
of the. Truitt,
E. B., Jr.
(E.),
556
Child and Juvenile Delinquency, Symposia on, edited by B. Karpman, review by W. Warren
(R.),
1127
‘¿,
psychiatry,
trends
in,
the
Thirty-third
Maudsley
Lecture,
by
L.
Kanner,
581
Childhood anxieties, relation between birth duration and, 1045
Children, pseudo-mental-deficiencysyndrome in, 406
Children's apperception test, 359
Chlorpromazine
and secobarbital, a comparison of the psychological effects of acute and
chronic administration of, in schizophrenic patients, by C. Kornetsky,
et a!., 190
,,
and
promazine,
quantitative
comparison
of
clinical
effectiveness
of,
by
T. H. Gilmore and L. Shatin, 508
,,
the
,,
and
use
,,
promazine
of,
in
a
“¿Vespral―
mental
deficiency
institution,
in
chronic
schizophrenic
a
placebo,
comparative
and
by
H.
patients,
P.
Robb,
1029
199
investigation,
349
Cingulate gyrus, somatic and visceral responses from the. Showers, M. J. C., and Crosby,
E.C.(E.),
571
Cingulates and behavior, the. Pechtel, C., et a!. (E.), 556
COLLINS,
G. H., and
,,
B@sssrr,
TAYLOR,
M., The effect
A.
L.,
ASHBY,
W.
of E.C.T.
Ross
and
on initiative,
B@ssm,
M.,
863
A
clinical
trial
of
Covatin
on elderly patients with anxiety and restlessness, 504
Organization and Science, by J. Rothstein, review by W. Ross Ashby (R.),
Communication,
267
Conditioned responses in relation to learning theory and behaviour theory, 61
Convulsion treatment, by hexafluorodiethyl ether, in psychiatric treatment. (E.), 559
Copper, serum in schizopbrenics. (E.), 511
Correlates ofcertainty, abnormal and personality, by J. C. Brengelmann, 142
CORSELLIS, J. A. N., and BRIERLEY, J. B., Observations
on the pathology
of insidious
dementia
following head injury, 714
Cortical pacemaker, studies on the. Garoutte, B., and Aird, R. B. (E.), 533
Covatin, a clinical trial of, on elderly patients with anxiety and restlessness,by W. Ross Ashby,
M. Bassett, G. H. Collins and A. L. Taylor, 504
CRAIrr, M. J., Tranquilizers,
482
CREASY, M. A., Some criticism offactor
analysis
with suggestions
for alternative
methods,
755
Criminal psychopaths, a follow-up study of, by T. N. C. Gibbens, D. A. Pond and D. Stafford
Clark, 108
Cutis anserina, by L. L. Havens, J. F. Harty and J. E. Cawte, 833
D'usns, A. R., and HEGARTY,J. G., A controlled study of the effectiveness of trifluopromazine
hydrochloride, 811
Day hospital for neurotics in an industrial community, a, by J. A. Harrmgton and W.
Mayer-Gross, 224
Delinquent and psychopathic behaviour, stress reactivity in relation to, by J. E. Tong, 935
Delinquency, Child and Juvenile, Symposia on, ed. by S. Karpman (R.), 1127
Dementia following head injury, pathology of, 714
,,
paralytica,
‘¿,
the
,,
at
origin
the
and
time
spread
of
of,
Robert
by
E.
H.
Schumann's
Hare,
594
death
in
1856,
a
note
on
the
concept
of,by A. Meyer,116
DENMARK,
J. C.,
and
LEYBERG, J. T., The
treatment
of depressive
states
with
imipramine
hydrochloride (Tofranil), 1123
Depression in women, the assessment of some symptoms and signs of, by G. A. Foulds and
T.M. Caine,
182
‘¿
‘¿
See
also
under
Anti-depressant
Depressive states, clinical syndromes in, by M. Hamilton and J. M. White, 985
,‘
,,
prognostic
,,
,,
the
factors
treatment
in
of,
with
the
E.C.T.
of,
imipramine
by
J.
M.
Roberts,
hydrochloride
I,
(Tofranil),
693,
II,
703
by
J.
T.
Leyberg and J. C. Denmark, 1123
,,
,,
hydroxyzine
,,
‘¿,
treatment
in,
with
792
imipramine
(Tofranil),
1123
Disseminated sclerosis. See Multiple sclerosis
Deserpidine and reserpine, a clinical trial of, in the treatment of the chronic schizophrenic, by
G. A. Dransfield and M. W. Browne, 1112
Disulfiram and citrated calcium carbimide in the treatment ofalcoholism, by M. M. Glatt, 476
DRANSFIELD,
G. A., and BROWNE, M. W., A clinical
treatment of the chronic schizophrenic, 1112
D.R.T. performance in schizophrenia, 1119
Drugs, response to, and psychiatry, by E. Marley, 19
trial of deserpidine
and reserpine
in the
1132
INDEX
EARLY, D. F., Psychosis
in association
with haemophilia,
243
E.C.T. , changes in catechol amine response to successive, 821
,,
controlled
,,
deaths
trial
of
straight
associated
,,
effect
,‘
in
of,
,,
learning
,,
modified
and
with,
on
by
initiative,
depressive
by
C.
by
Barker
Seager,
and
A.
C.
A.
P.,
1022
Baker,
339
863
states,
ability
modified,
J.
prognostic
during
a
factors
course
suxethonium,
of
in,
20,
693,
703
1017
prolonged
apnoea
following,
by
J.
C.
Barker
and
A.
May,
496
, ,
premedication
EDELSTEIN,
with
meprobamate,
E. L., Kn@&ssn.owsiCv,
acute schizophrenics,
EDGECOMBE,
human
P. C. E., et al.,
K.
and
GDALIA,
J. , A study
on serum
copper
level
in 20
511
behaviour,
EDWARDS,
241
D.,
Potentiation
by phenobarbitone
of effects
of ethyl
alcohol
on
51
C. S.,
and
MIDDLEFELL, R.,
Hydroxyzine
(Atarax)
in the
relief
of tension
associated with anxiety neurosis and mild depressive states, 792
EEG after arousal from barbiturate narcosis, 788
,,
changes
, ,
during
and
hyperanimonemia.
sleep,
cyclic
variations
and Kleitman,
,,
findings
in
acute
Poser,
C.
and
their
in,
M.
(E.),
531
relation
to
eye
movements,
etc.
Dement,
Petersen,
P.
W.,
N. (E.), 530
carbon
monoxide
poisoning.
Lennox,
M.
A.,
and
B.
(E.),
531
,,
frequency-pattern
,,
in
, ,
of
N-N
variation
and
diethyltryptamine
normal,
intelligence.
Ellingson,
intoxication,
full-term
newborns
R.
J.,
et
a!.
(E.),
530
176
immediately
after
birth
with
observations
on
arousal
and visual evoked responses. Ellingson, R. J. (E.), 531
,,
rhinencephalic,
,,
the
and
effects
of
two
behaviour.
(E.),
antiserotonin
530
substances
(BAS
and
BAB)
and
of
bufotenin
on.
Rinaldi,
F. (E.), 557
,,
under
hypoglycaemia
in
EITINGER, L., The incidence
cases
of
narcolepsy,
of mental
163
disease
among
refugees
in Norway,
326
Electric activity of the brain, the effects of two antiserotonin substances (BAS and BAR) and
of bufotenin on the spontaneous. Rinaldi, F. (E.), 557
Electropallidoansotomy, long-range effects of, in extrapyramidal
Spiegel, E. A., et a!. (E.), 573
Electroplexy,
controlled
,,
deaths
trial of straight
associated
with,
and modified,
by
J.
C.
Barker
by Seager,
and
A.
A.
and convulsive disorders.
C. P., 1022
Baker,
339
Emotion and blood-pressure, by G. Innes, W. M. Millar and M. Valentine, 840
Enuresis, pituitary snuff and propantheline in the treatment of, 371
Enzymes of C.N.S., effect of tranquillizers on, 569
Epidemiological
research,
principles
and methods
illness, by S. L. Morrison, 999
of, and their
application
to psychiatric
Epidemiology of mental illness, national statistics in, 893
Epilepsy, a new drug for petit mal. Zimmerman, F. T., and Burgemeister, B. B. (E.), 573
, ,
See
,,
uncinate
also
under
Anti-convulsant
fits.
(E.),
569
Epileptic cephalea. Halpern, L., and Bental, E. (E.), 572
Epinephrine and norepinephrine in changing emotional states, circulating. Regan, P. F., and
Reilly, J. (E.), 560
ESP and Personality Patterns, by G. R. Schmeidler and R. A. McConnell, review by W.
Ross Ashby (R.), 1127
Ethycrotonylurea, a controlled trial of, by J. P. Baker, 852
EVARTS,
E.
V. , el a!.,
A comparison
of
the
psychological
effects
of
acute
and
chronic
administration of chlorpromazine and secobarbital in schizophrenic patients, 190
Expressive
movement
and learning,
EYSENCK, H. J., The inheritance
,,
Learning
,,
The
,,
Some
FABISCH,
W.,
theory
and
Rees-Eysenck
criticisms
trial
with
a reply,
behaviour
Body
recent
A clinical
by J. C. Brengelmann,
of neuroticism:
therapy,
Index
of
and
the
a new
81
76
61
Sheldon's
dimensional
Somatotype
analysis
anticonvulsant
drug,
System,
of
personality,
1053
220
a-(p-aminophenyl)-a-ethyl
glutarimide, preparation 16038 (Ciba), 448
Factor
analysis,
some
criticisms
of, with suggestions
for alternative
methods,
by M. A. Creasy,
755
Fastigial nuclei in the cat, isolated lesions of the. Carpenter, M. B., et a!. (E.), 541
Fentazin. See Perphenazine
FERGUSON, R. S., Reserpine
and chronic
psychosis,
251
FLEISCHHACKER, H. H., LANCASTER, J. B., and WHEELER, A. P., Studies
Disturbances
,,
of protein
and
and tryptophan
LANCASTER,
J.
metabolism
B.,
Studies
and toxicity
in
schizophrenia,
and the “¿glyoxy@lic
acid―reaction, 777
in Schizophrenia,
V.
of urine, 313
VI.
Urinary
indoles
INDEX
FLEMING,
B. G.,
SPENCER,
A. M.,
and
1133
WHITELAW,
E. M.,
A controlled
comparative
investi
gation of the effects of promazine, chlorpromazine and a placebo in chronic psychosis,
349
FORREST,
A. D., Indoluria
,,
Indoluria
,,
and
in schizophrenia
: I, 674
in
: II,
schizophrenia
URQUHART,
R.,
685
Clinical
trial
of
promazine
hydrochloride
and
acetyl
promazine in chronic schizophrenic patients, 260
FOULDS, G. A., The relative
stability
of personality
measures
compared
with
diagnostic
measures, 783
,,
and
,,
C@miE,
T.
,,
M.,
The
,,
assessment
ofsome
in women,
182
Symptom
clusters
neurotic
FRANCE,
N. E., NORMAN,
in gargoylism,
R. M., and
URICH,
symptoms
and
personality
men compared
H.,
and
Perivascular
signs
of
types
among
with women,
cavitation
depression
psycho
469
of the basal
ganglia
1070
Frenquel (azacyclonal) in chronic schizophrenia, 210, 247, 526
GALBRAITH,
A. J., HEWAT, J. K., and
MACNAMARA,
D., “¿Stemetil―in the treatment
of chronic
psychotics, 256
Galvanic
skin response
in psychiatric
patients,
adaptation
and conditioning
of the, by M. A.
Stewart, et al., 1102
Gargoylism, perivascular cavitation of the basal ganglia in, by R. M. Norman, H. Urich and
N. E. France, 1070
GDALIA, J., EDELSTEIN, E. L., and KRASSILOWSKY, D. , A study on serum copper
level in 20
acute schizophrenics, 511
General paralysis. See Dementia paralytica
GEORGE,
E. I., PAYNE, R. W.,
and
MATI-USSEK,
P., An experimental
study
of schizophrenic
thought disorder, 627
GIBBENS, T. C. N. , Por@n, D. A. , and STAFFORD-CLARK, D. , A follow-up
study of criminal
psychopaths, 108
Gilles de Ia Tourette's disease, by S. Bockner, 1078
GELMORE, T. H., and
SHATIN, L., Quantitative
comparison
of chlorpromazine
and
promazine,
508
GLATr,
M. M., Disuifiram
,,
KAY,
and citrated
W.
W.,
and
calcium
MURFITT,
carbamide
K.
C.,
in the treatment
Liver
damage
in
ofalcoholism,
addictive
476
alcoholics,
748
Glutamic oxalacetic transaminase in C.S.F. Miyazaki, M. (E.), 556
Glutarimide
derivative
GRADWELL,
B. G.,
as anticonvulsant,
MAY, A. R., and
448
WHITELEY,
J. S. , Trifluoperazine
(Stelazine)
in psycho
neuroses,
1059
GREGORY,
I., Husbands
and
wives
admitted
to mental
hospital,
457
Group psychotherapy in a day hospital, 230
Haemophilia, psychosis in association with, by D. F. Early, 243
Hallucinations, auditory, in chronic alcoholism, the phenomenon of. Victor, M., and Hope,
J. M. (E.), 559
HAMILTON, M. , and WHJn@, J. M. , Clinical
syndromes
HARE, E. H., The origin and spread of dementia
HARGREAVES, M. A. , An investigation
into the
in depressive
states, 985
paralytica,
594
effects of azacyclonal
on the
hallucinations
of chronic schizophrenic patients, 210
HARRINOTON,
J. A.,
and
MAYER-GROSS,
W.,
A day
hospital
for
neurotics
in an
industrial
community, 224
HARRIS, A., Sensory
deprivation
and schizophrenia,
235
HARTY, J. F., HAVENS, L. L., and CAWTE, J. E., Cutis anserina,
HAVENS, L. L., et al., Changes
,,
HARTY,
J.
F.,
in catechol
and
amine response
CAwm,
J.
E.,
Cutis
833
to successive
anserina,
E.C.T.s,
821
833
Head injury, observations on the pathology of insidious dementia following, by J. A. N.
Corsellis
and J. B. Brierley,
HEASMAN, M. A., and
BEAiTIE,
714
M. K., Adrenal
lipoids
DARnS, A. R., A controlled
study
as seen post
mortem
in schizophrenia,
979
HEGARTY,
J. G., and
hydrochloride, 811
of the effectiveness
of trifluopromazine
HEWAT, J. K., MACNAMARA, D., and GALBRAITH, A. J., “¿Stemetil―
in the treatment
of chronic
psychotics, 256
Hexafluorodiethyl
ether (Indoklon),
Esquibel, A. J., et al. (E.), 559
HINTON,
J.
M.,
A comparison
its
use
as
of perphenazine
a convulsant
(Fentazin),
in psychiatric
sodium
treatment.
amylobarbitone
and
placebo in anxious and depressed out-patients, 872
HOENIG,
J., and
SREENJVASAN, U.,
Mental
hospital
HOFFER, A., and O5M0ND, H., Schizophrenia:
admissions
a new approach,
in Mysore
653
Homosexuality among Oxford undergraduates, by S. J. G. Spencer, 393
Husbands
and wives admitted
to mental
hospital,
by I. Gregory,
457
State,
India,
124
a
1134
INDEX
Hydrocortisone plasma level, relation of emotional responses and changes in, after stressful
interviews. Persky, H. (E.), 521
5-Hydroxytryptophan, effects of, in schizophrenia, 770
Hydroxyzine (Atarax) in the relief of tension associated with anxiety neurosis and mild
depressive
states, by R. Middlefell
and K. C. S. Edwards,
792
Hypnosis : re-hypnotization after a patient's refusal, 795
Inadequate personality in psychiatric practice, 44
India (Mysore State), mental hospital admissions in, 124
Indoluria, in psychotic and normal subjects. (E.), 524
,,
,,
,,
,, schizophrenia
,,
,,
,,
,,
and the glyoxylic
acid reaction,
I, by A. D. Forrest,
674
II, by A. D. Forrest,
685
INGLIS, JAMES, A paired-associate
,,
,,
On
the
learning
prognostic
777
test for use with elderly psychiatric
value
of
the
modified
word
learning
patients,
test
in
440
psychiatric
patients over 65, 1100
Initiative, the effect of E.C.T. on, by G. H. Collins and M. Bassett. 863
INNES, G.,
MILLAR,
W. M., and
VALENTINE,
M., Emotion
and
blood-pressure,
840
Intellectual impairment, testing for, by M. Piercy, 489
Iproniazid and tryptophan, observations on schizophrenic patients after. Lauer, J. W., et a!.
(E.), 524
Iran, Psychometric
testing in, 93
JoHNsON, J., Anticonvulsants
and megaloblastic
anaemia, 819
JONES, K., Admission to mental hospital after thyroidectomy,
803
Jor@izs,
K. S., and TIBBETS,
R. W., Pituitary snuff, propantheline and placebos in the treatment
ofenuresis,
371
JOYCE, C. R. B., et a!., Potentiation
by phenobarbitone
of effects
of ethyl
alcohol
on human
behaviour, 51
[email protected],L., The Thirty-third
KAY, W. W., Muitrrrr,
Maudsley
Lecture: Trends in child psychiatry,
K. C., and GLATr,
KENNARD, D. A., et a!., Potentiation
behaviour, 51
M. M., Liver damage
by phenobarbitone
581
in addictive
alcoholics,
of effects of ethyl alcohol
74S
on human
Kernicterus in relation to microcephaly, 738
KIRMAN, B. H., Wiw@&i@ss,C. E., and BRANDON, M. W. G., Microcephaly,
721
KLEE, G. D., Wen'niuwn,
W., and Bnam@io, J. R., Effects of certain vitamins and histamines
on the LSD psychosis, 1095
KORNETSKY, C., et al., A comparison
of the psychological
effects of the acute and chronic
administration of chiorpromazine and secobarbital in schizophrenic patients, 190
KRASSILOWSKY,
D.,
[email protected],
J., and
ED@smm@,
E. L., A study
on serum
copper
level
in 20
acute schizophrenics, 511
KRATrER,
F. E., A case
,,
The
of phocomelia
physiognomic,
associated
with
psychometric,
severe
mental
behavioral
deficiency,
and
830
neurological
aspects
of
phenylketonuria, 421
,,
The
pseudo-mental-deficiency
syndrome,
406
Ka@wreciu,J. A., BL@ia,R. A., and SHAFAR,
S., Methylphenidate (Ritalin), 1032
LANCASTER, J. B., and
FLEISCHHACKER,
H. H., Studies
in schizophrenia—VT.
Urinary
indoles
and the “¿glyoxylic
acid―reaction, 777
,,
WHEELER,
A.
P., and
FLEISCHHACKER,
H.
H.,
Studies
Disturbance of protein and tryptophan
urine, 313
LASCELLES, C. F., and LEVENE, L. J., A study
ofthe
in schizophrenia—V.
metabolism and toxicity of
use ofazacyclonal
hydrochloride
(Frenquel)
in chronic schizophrenia, 247
Learning ability during a course of 20 E.C.T., by J. G. Thorpe, 1017
,,
,,
expressive
movements
theory
and behaviour
and, 81
therapy,
by H.
J. Eysenck,
61
Leucotomy.SeeLobotomy
LEVENE, L. J., and LASCELLES,C. F., A study ofthe
use ofazacyclonal
hydrochloride
(Frenquel)
in chronic schizophrenia, 247
LEWIS, W. H. P., and STERN, J., The serum lipoproteins
LEYBERG, J. T., and DEr@@u@iuc,
J. C., The treatment
hydrochloride (Tofranil), 1123
Limbic system with respect to self-preservation
MacLean,
of mentally retarded children, 1012
of depressive states with imipramine
and the preservation of the species, the.
P. D. (E.), 560
Lipoprotein, serum, in mentally retarded children, 10, 12
Liver damage in addictive alcoholics, by W. W. Kay, K. C. Murfitt, and M. M. Glatt, 748
Lobotomy, prefrontal, the prediction and assessment of psychological changes following, by
P. McReynolds
and M. Weide, 971
LSD 25, clinical and laboratory observations on. Feld, M., et al. (F.), 556
,,
,,
,, effects
‘¿
, further
of, on intellectual
work on, 660
functions.
Silverstein,
A.
B.,
and
Klee,
G.
D.
(E.),
526
INDEX
L.S.D.
,,
1135
25, studies on the effect of. Liebert, R. S., et al. (E.), 522
psychosis,
effects
ofcertain
vitamins
and
histamines
on
the,
by
J.
R.
Bertino,
G.
D.
Klee
and W. Weintraub, 1095
,,
See
also
under
5-Hydroxytryptophan
“¿Lunacy,
on thestate
of―
1859-1959,
by A. Walk,879
Lysergic acid diethylamide. See LSD
MACNAMARA,
D., G,@iBn@rm,
A. J., and HEwAT,
J. K., “¿Stemetil―in the treatment
of chronic
psychotics,
256
MARLEY, E., Response
,,
and
,,
to drugs
and psychiatry,
BARThOLOMEW,
A.
,,
A.,
,,
19
Susceptibility
to
The
reliability
temporal
methylpentynol,
957
of
the
Maudsley
Personality
Inventory, 238
MATHER,
M., BLACK, D. A., and
WALTON,
D., The
validity
of the Meehi
M.M.P.I.
psychotic
scale in the diagnosis of schizophrenia, 869
MATrUSSEK,
P., GEORGE,
E. I., and
PAYNE, R. W.,
An experimental
study
of schizophrenic
thought disorder, 627
Maudsley Lecture, the Thirty-third: Trends in child psychiatry, by L. Kanner, 581
,,
Personality
Inventory,
391
,,
,,
,,
in
,,
,,
‘¿,
the
relation
to
susceptibility
temporal
t3
reliability
of
methylpentynol,
the,
by
A.
957
A.
Bartholomew
and
E. Marley, 238
MAXWELL, A. F., Models
for prediction
MAY, A., and BARKER, J. C., Prolonged
purposes,
apnoea
(Brevidil “¿E―),
496
463
following
MAY, A. R., WHITELEY, J. S., and GRADWELL, B. 0.,
E.C.T.
modified
Trifluoperazine
by suxethonium
(Stelazine)
in psycho
neuroses,
1059
@
MAYER-GROSS,
community,
W., and
224
HARRINGTON,
J. A.,
A day
hospital
for neurotics
in an industrial
MCGEER, E. G., and P. L., Physiological
effects of schizophrenic
body fluids, I
MCGEER,
effects
body
P. L., and
McR@mows,
E. G.,
Physiological
of schizophrenic
fluids,
1
P., and WEIDE,M., The prediction and assessment of psychological changes
following prefrontal lobotomy, 971
Megimide (bemegride), observations on arousal following, during light barbiturate narcosis,
by B. Ackner and G. Pampiglione, 788
Memory, exceptional for dates or weather, in a schizoid psychopath, 550
Mental deficiency,aspects of phenylketonuria, 421
,,
,,
associated
,,
,,
mongoloid,
,,
,,
pseudo-,
,,
,,
See
also
,,
,,
use
of
,,
illness,
national
with
phocomelia,
paranoid
830
schizophrenia
in,
444
406
under
Microcephaly
chlorpromazine
statistics
in,
in
the
1029
epidemiology
of,
by
E.
M.
Brooke,
893
Mentally retarded children, the serum lipoproteins of, by J. Stern and W. H. P. Lewis, 1012
Meprobamate, premedication for E.C.T. with, by D. L. C. Thomas, 241
Mescaline, studies on, VIII. Denber, H. C. B. (E.), 520
Methacholine and methylamphetamine, prognostic tests in E.C.T., 702
Methamphetamine
and amylobarbitone,
influence
of, on attention,
382
Methylpentynol, susceptibility to, by A. A. Bartholomew and E. Marley, 957
Methylphenidate (Ritalin), by R. A. Blair, S. Shafar and J. A. Krawiecki, 1032
MEYER, A., A note on the concept
of dementia
paralytica
at the time of Robert
Schumann's
death in 1856, 116
Microcephaly, by M. W. G. Brandon, B. H. Kirman and C. E. Williams, 721
MIDDLEFELL,
R.,
and
EDWARDS,
K.
C.
S.,
Hydroxyzine
(Atarax)
in the
relief
of tension
associated with anxiety neurosis and mild depressive states, 792
MILLAR,
M.M.P.I.
W. M., VALENTINE,
psychotic
M., and
Ir'm@s, 0.,
scale (Meehl) in diagnosis
Emotion
and
blood-pressure,
of schizophrenia,
840
validity of, 867
Model psychoses, 36
Models for prediction purposes, by A. E. Maxwell, 463
Mongolism in relation to microcephaly, 741
Mongoloid defective, paranoid schizophrenia in a, 444
Monoureide and diureide sedatives, a comparison of, Feinblatt, T. M., et a!. (E.), 554
MONRO, A. B., The inadequate
personality
in psychiatric
MORRISON, S. L., Principles
and methods
of epidemiological
practice,
44
research
and
their
application
to
psychiatric illness, 999
Multiple sclerosis, C.S.F. free cholesterol an index of activity in. (E.), 525
,,
,,
impairment
,,
‘¿,
studies
of
,‘
,,
subcutaneous
on.
abstracting
Ferraro,
A.
hemorrhages
ability
(E.),
in.
Parsons,
0.
A.,
et
a!.
(E.),
554
561
in.
Swank,
R.
L.
(F.),
571
Muiu@rrr, K. C., GLATr, M. M., and KAY, W. W., Liver damage in addictive alcoholics, 748
Mysore State, India, mental hospital admissions in, by J. Hoenig and U. Sreenivasan, 124
1136
INDEX
NAGY, T., D@it, P., and BOszOiu@iEtwi,
Z., Observations
on the psychotogenic
effect
of N-N-
diethyltryptamine, 171
Narcolepsy and hypoglycaemia, by C. M. Smith and R. A. Schneider, 163
,,
syndrome,
the.
Ganado,
W.
(E.),
571
Neuroticism, the inheritance of: a reply, by H. J. Eysenck, 76
NEviu..E, J., Paranoid schizophrenia in a mongoloid defective, 444
N-N-diethyltryptamine,
Ddr
and
observations
T. Nagy,
on the psychotogenic
effect of, by Z. Boszorményi, P.
171
Noiu@tri, R. M., URJCH,H., and FRANCE,N. E., Perivascular cavitation of the basal ganglia
in gargoylism, 1070
Norway, mental disease among refugees in, 326
,,
care
and
treatment
of
psychopathic
offenders
in,
428
Object relations technique performance in schizophrenics, by J. E. Orme, 1118
O'Cor'mtoR, N., and VENABLES,
P. H., A short scale for rating paranoid schizophrenia, 815
Oculogyric crises, phenothiazine toxicity and, 798
ORME, J. E., O.R.T.
performance
in schizophrenia,
1119
OsMot@in,H., and Horrna, A., Schizophrenia: a new approach, 653
Osw,@w,I., Deliberate re-hypnotization after the patient's refusal, 795
,,
Experimental
studies
of
rhythm,
anxiety
PAMPIGUONE, G., and Acio@rna, B., Observations
and
cerebral
on arousal
vigilance,
following
269
Megimide
(bemegride)
during light barbiturate narcosis, 788
Paranoid delusions, a preliminary experiment on, by M. B. Shapiro and A. T. Ravenette, 295
,,
schizophrenia
‘¿,
in
,,
a mongoloid
short
PARE, C. M. B., SANDLER,
schizophrenia,
scale
M.,
defective,
for
and
rating,
by
J.
Neville,
444
815
BRENGELMANN,
J. C., Effects
of 5-hydroxytryptophan
in
770
PAULSON, G., Phenothiazine
PAYNE, R. W., MAITUSSEK,
toxicity,
P., and
extrapyramidal
seizures
and oculogyric
GEORGE, E. I., An experimental
study
crises, 798
of schizophrenic
thought disorder, 627
Pecazine (Pacatal) compared with amylobarbitone sodium in anxiety states, by A. A. Robin,
1064
Perphenazine (Fentazin), sodium amylobarbitone and a placebo. a comparison of, in anxious
and depressed out-patients, by J. M. Hinton, 870
Persia, psychometric testing in, 93
Personality
correlates
,,
Inventory,
,,
measures
of certainty,
the
142
Maudsley,
compared
temporal
with
reliability
diagnostic
of,
measures,
238
the
relative
stability
of,
by
G.
A.
Foulds, 783
,,
some
,,
testing
recent
,‘
the
,,
type
in
criticisms
Iran,
inadequate,
in
of
the
dimensional
analysis
of,
by
H.
J.
Eysenck,
220
99
in
psychiatric
psychoneurotic
men
practice,
by
compared
A.
with
B.
Monro,
women,
44
469
PErrrrr, M., et al., A comparison of the psychological effects of acute and chronic adminis
tration of chlorpromazine and secobarbital in schizophrenic patients, 190
Phenobarbitone, potentiation by, of effectsof ethyl alcohol on human behaviour, by C. R. B.
Joyce, et al., 51
Phenothiazine toxicity, extrapyramidal seizures and oculogyric crises, by G. Paulson, 798
Phenylketonuria, the physiognomic, psychometric, behavioral and neurological aspects of,
by F. E. Kratter, 421
Phenyltoloxamine, psycho-physiologic evaluation of. DiMascio, A., et al. (E.), 520
Phocomelia, a case of, associated with severe mental deficiency. by F. E. Kratter, 830
Pick's disease, the histologic structure of the inclusion bodies of the neurons in. Scharenberg,
K. (E.), 562
PLERCY, M., Testing for intellectual
PILKINGTON, T. L., Prochiorperazine
impairment,
(Stemetil)
489
in mental
deficiency,
215
Pituitary snuff, propantheline and placebos in the treatment of enuresis, by K. S. Jones and
R. W. Tibbetts,
371
Po@m,D. A., STAFFORD-CLARK,
D., and GIBBENS,
T. C. N., A follow-up study of criminal
psychopaths, 108
Prochlorperazine (Stemetil) in mental deficiency, by T. L. Pilkington, 215
,,
,,
in
treatment
of
chronic
psychotics,
256
Promazine and chlorpromazine, quantitative comparison, 508
,‘
chlorpromazine
and
a placebo,
a controlled
comparative
investigation
ofthe
effects
of, in chronic psychosis, by B. 0. Fleming, A. M. Spencer and E. M. Whitelaw,
349
,,
hydrochloride
and
acetyipromazine,
clinical
trial
of,
patients, by R. Urquhart and A. D. Forrest, 260
Propantheline in treatment of enuresis, 371
Pseudo-mental-deficiencysyndrome, the, by F. E. Kratter, 406
in
chronic
schizophrenic
INDEX
1137
Psychiatric patients over 65, on the prognostic value of the modified word learning test in by,
J. Inglis, 1100
,,
,,
a
paired-associate
learning
test
for
use
with
elderly,
by
James
Inglis,
440
Psychometric testing in Iran, by M. Valentine, 93
Psychoneuroses, trifluoperazine in, 1059
Psychoneurotic men compared with women, symptom-clusters and personality type among, 469
Psychotogenic drugs. See under LSD, N-N-diethyl-tryptamine, mescaline
Psychotomimetic drugs, 662
Psychopathic and delinquent behaviour, stress reactivity in relation to, 935
,,
offenders
in
Norway,
Sweden
and
Denmark,
the
care
and
treatment
of,
by
P. G. Aungle, 428
“¿Psychopathic―
depression, 989
Psychopaths, criminal, follow-up study of, 108
Psychopathy. See also under Personality, the inadequate
RAvENETrE, A. T., and SHAPIRO, M. B., A preliminary
experiment
on paranoid
delusions,
295
Rees-Eysenck body index, the, and Sheldon's somatotype system, by H. J. Eysenck, 1053
Refugees in Norway, the incidence of mental disease among, by L. Eitinger, 326
Re-hypnotization, deliberate, after the patient's refusal, by I. Oswald, 795
Reserpine and chronic psychosis, by R. S. Ferguson, 251
‘¿,
therapy
on
a
group
of
severely
disturbed
psychotics,
psychologic
changes
induced
by. Tanck, R. H. (E.), 558
,,
,,
deserpidine
in
treatment
of
the
chronic
schizophrenic,
1112
Reticular formation of the brain, the effect of drugs on arousal responses produced by electrical
stimulation of the. Bradley, P. B., and Key, B. J. (E.), 531
Rhinencephalic
electrograms,
‘¿,
lesions
Rhinencephalon,
correlation
and
behavior
of, with behavior.
in
cats.
Green,
J.
D.,
Monroe,
et
al.
R. R., et al. (E.), 530
(E.),
541
viscero-sensory and somato-sensory representation
in the. Dunlop, C. W.
(E.), 533
Rhythm, anxiety and cerebral vigilance, experimental studies of, by I. Oswald, 269
Ritalin (methylphenidate), 1032
ROBB, H. P., The use of chlorpromazine
in a mental deficiency
ROBERTS, J. M., Prognostic
factors in the E.C.T. of depressive
,,
Prognostic
factors
in
the
E.C.T.
of
institution,
1029
states—I, 693
depressive
states—Il,
703
ROBIN,A. A., Pecazine (Pacatal) compared with amylobarbitone sodium in anxiety states, 1064
SANDLER,
M.,
BRENGELMANN,
J. C., and
P4'@ar, C. M. B., Effects
of 5-hydroxytryptophan
in
schizophrenia, 770
Scandinavia,
care and treatment
of psychopathic
offenders
in, 428
Schizoid psychopath, exceptional memory for dates and weather in a. Robertson, J. P. S. (E.),
550
Schizophrenia, adrenal lipoids as seen post mortem in, by M. K. Beattie and M. A. Heasman,
979
‘¿,
and
adrenochrome,
,‘
and
social
“¿
aromatic
,,
ceruloplasmin,
‘¿,
chronic,
,,
‘¿,
653
class,
1007
metabolism
in,
azacyclonal
,,
clinical
effects
I
transferrin
of
trial
and
II.
and
tryptophan
in.
(E.),
of
deserpidine
McGeer,
P.
in.
L.,
et
(E.),
al.
(E.),
554
524
526
and
5-hydroxytryptophan
on,
reserpine
by
J.
C.
in,
1112
Brengelmann,
C.
M.
B.
Pare
and
M. Sandier, 770
.
,,
indoiuria
in,
I,
,,
indoluria
in,
II,
,,
a
,,
neuraminic
,,
niacin
,,
O.R.T.
‘¿,
paranoid
new
by
A.
by
approach,
by
acid
of,
performance
,,
,,
,,
sensory
“¿
studies
a
scale
685
Osmond
and
in.
(E.),
A.
Hoffer,
653
525
657
in,
short
V.
H.
674
Forrest,
by
mongoloid
deprivation
in
Forrest,
D.
deficiency
treatment
in
D.
A.
J.
E.
Orme,
defective,
for
rating,
and,
1119
444
by
P.
H.
Venables
and
N.
O'Connor,
815
235
Disturbances
of
protein
and
tryptophan
metabolism
and
toxicity
of urine, by H. H. Fleischhacker, J. B. Lancaster and A. P. Wheeler, 313
,,
studies
in,
VI.
Paper
chromatography
of
urinary
indoles
and
the
glyoxylic
acid
reaction, 777
,,
thyroid
,,
the
therapy
validity
of.
of
D. Walton,
the
Danziger,
Meehi
L.
(E.),
M.M.P.I.
530
psychotic
scale
in
the
diagnosis
of,
M. Mather and D. A. Black, 869
Schizophrenic body fluids, physiological effects of, by E. G. McCIeer and P. L. McGeer, I
,‘
and
non-schizophrenic
mental
patients,
T. E., and Hall, R. (E.), 558
skin
histamine
reaction
in.
Weckowicz,
by
1138 ‘¿
INDEX
Schizophrenic patients, after iproniazid and tryptophan. (F.), 524
,,
,,
—¿comparison
of
chlorpromazine
and
secobarbital
(quinalbarbitone)
in, 190
,,
,,
chronic,
“¿Vespral―
,,
,,
chronic,
promazine,
,,
,,
effect
,,
,,
size
of
and
chiorpromazine
in,
acetylpromazine
azacyclonal
on
constancy
and
and
hallucinations
abstract
thinking
199
chlorpromazine
of,
210
in,
by
T.
in,
E.
260,
349
Weckowicz
and
D. B. Blewett, 909
,,
thought
disorder,
an
experimental
study
of,
by
R.
W.
Payne,
P.
Mattussek
and
E. I. George, 627
Schizophrenics, object relations technique in, 1119
,,
serum
copper
level
in.
(F.),
511
Schizophreniform syndromes in children, 416
SCHNEIDER, R. A., and Si@nm, C. M., Narcolepsy
and hypoglycaemia,
163
Schumann's death and the concept of dementia paralytica, 116
S@ona, C. P., Controlled trial of straight and modified electroplexy, 1022
Sedatives, mono- and diureide. (E.), 554
Senile patients, modified word learning test in, 1100
,,
,,
paired-associate
,,
,,
with
learning
anxiety
and
test
for,
restlessness:
trial
440
of
Covatin,
504
Sensory deprivation and schizophrenia, by A. Harris, 235
Septal and amygdaloid lesions, effects of, on emotional behavior and conditioned avoidance
responses in the rat. King, F. A. (F.), 555
Serotonin, benzyl analog of. (E.), 557
Serotonin content ofthe human brain, studies on the. Costa, E., and Aprison, M. H. (F.), 557
Serum copper level in 20 acute schizophrenics, a study on, by E. L. Edelstein, D. Krassiowsky
and J. Gdalia, 511
Sexual behaviour in psychiatric patients, use of stilboestrol for suppression of, 762
SHAFAR, S., KRAWIECKI,
J. A., and
[email protected], R. A., Methylphenidate
(Ritalin),
1032
Ssi@pmo,M. B., and R@vn@m, A. T., A preliminary experiment on paranoid delusions, 295
SHATIN, L., and
Gni@ioar,
508
T. H., Quantitative
comparison
of chlorpromazine
and
SMiTH, C. M., and Sci@emna,
R. A., Narcolepsy
and hypoglycaemia,
163
SMITh, S., An investigation
and survey of 27 cases of akinesis
with mutism
promazine,
(stupor),
1088
Somatotype system and the Rees-Eysenck Body Index, 1053
Somatotypes in relation to homosexuality, 395
Speech and the Development of Mental Processes in the Child, by A. R. Luria and F. Ia
Yudovick, reviewed by W. Warren (R.), 1128
Spsi'jcj@a,A. M., Fi@imio, B. G., and Wmmi@w, E. M., A controlled comparative investi
gation of the effects of promazine, chlorpromazine and a placebo in chronic psychosis,
349
SPENCER, S. J. G., Homosexuality
among Oxford undergraduates,
393
SREENIvASAN, U., and Hosr'ao, J., Mental hospital admissions in Mysore
STAFFORD-CLARK,
D.,
GIBBENS, T. C. N.,
and
Por@D, D. A.,
State, India,
A follow-up
study
124
of criminal
psychopaths, 108
Statistics, national, in the epidemiology of mental illness, 893
Stelazine (trifluoperazine) in psychoneurosis, by A. R.' May, J. S. Whiteley and B. U.
Gradwell, 1059
“¿Stemetil―
in the treatment of chronic psychotics, by A. J. Galbraith, J. K. Hewat, and D.
MacNamara, 256
,,
(prochlorperazine)
in
mental
deficiency,
by
STERN, J., and Lswis,
W. H. P., The serum lipoproteins
STEWART,
al.,
M.
A.,
et
psychiatric patients,
Stilboestrol, the clinical
psychiatric patients,
Students, homosexuality
Adaptation
and
conditioning
T.
L.
Pilkington,
215
of mentally
of
the
retarded
galvanic
children,
skin
1012
response
in
1102
use of, for suppression of sexual behaviour of chronically ill male
by J. D. Adarnson, 762
among, 393
Stupor, investigation and survey of, 1088
Symptom clusters and personality types among psychoneurotic men compared with women,
by 0. A. Foulds and T. M. Caine, 469
TAYLOR, A. L., ASHBY, W. Ross,
B,@ssErr, M., and CoLLINS, U. H., A clinical
trial of Covatin
on elderly patients with anxiety and restlessness, 504
Temporal lobe, mental symptoms in cases of tumor of. Gal, P. (F.), 519
Therapeutic trials. See under Trials
Thiopropazate hydrochloride (Dartal) chemotherapy for emotional disorders. Eclisen, C. B.,
and Samuels, A. S. (F.), 526
ThoMAS, D. L. C., Premedication
THORPE, J. G., Learning ability
,,
and
[email protected],
A.
for E.C.T. with meprobamate,
during a course of 20 E.C.T.,
A.,
Trials
and
tribulations,
1082
241
1017
INDEX
1139
Thyroidectomy, admission to mental hospital after, by K. Jones, 803
TIBBEYSS, R. W., and JoNzs,
K. S., Pituitary
snuff,
propantheline
and placebos
in the treatment
ofenuresis, 371
Tics, convulsive (Gilles de la Tourette's Disease), 1078
TONG,
J. E., Stress
Tranquilizers,
reactivity
in relation
to delinquent
and
psychopathic
behaviour,
935
by M. J. Craft, 482
,,
effect
,,
See
of,
on
also
C.N.S.
under
enzymes.
(E.),
569
Acetylpromazine
zinc (Suavitil),
(Notensil),
Chlorpromazine
Azacyclonal
(Largactil),
(Frenquel),
Benacty
Ethylcrotonylurea,
Hydroxy
zinc (Atarax), Imipramine (Tofranil), Methylpentynol (Oblivon), Pecazine
(Pacatal), Perphenazine(Fentazin), Prochlorperazine(Stemetil), Promazine
(Sparine), Thiopropazate (Dartal), Trifluoperazine (Stelazine), Trifluo
promazine (Vespral)
Tranquillizing agents : atropine-like poisoning due to, 520
Trials and tribulations, by A. A. Baker and J. G. Thorpe, 1082
Trifluoperazine
(Stelazine) in psychoneuroses,
by A. R. May, J. S. Whiteley and B. G.
Gradwell,
1059
Trifluopromazine hydrochloride, a controlled study of the effectiveness of, by J. 0. Hegarty
and A. R. Dabbs, 811
,,
(“Vespral―)
and
chlorpromazine,
the
relative
efficacy
in
the
treatment
of
a
group of chronic schizophrenic patients, by G. P. Walsh, D. Walton,
and D. A. Black, 199
Tryptamine derivatives, 37, 171, 557
Tryptophan, 5 hydroxy-, effects on schizophrenia, 770
,,
metabolism
in
schizophrenia,
313
Uncinate fits. Daly, D. (E.), 569
URICIS, H.,
FRANCE,
N. E., and
NORMAN,
R. M.,
Perivascular
cavitation
of the basal
ganglia
in gargoylism, 1070
Urinary excretion of 5-hydroxyindoleacetic acid in psychotic and normal subjects. Buscaino,
G. A., and Stefanachi, L. (E.), 524
URQUHART,
R.,
and
FORREST,
A. D.,
Clinical
trial
of promazine
hydrochloride
and
acetyl
promazine in chronic schizophrenic patients, 260
VALENTINE,
M., Psychometric
,,
INNES,
G.,
testing
and
in Iran,
MILLAR,
93
W.
M.,
Emotion
and
blood-pressure,
840
Values, the Measurement of, by L. L. Thurstone, review by W. Ross Ashby (R.), 1127
VENABLES, P. H.,
and
O'Cor@oR,
N.,
A short
scale
for rating
paranoid
schizophrenia,
815
“¿Vespral―.
See Trifluopromazine
Visceral brain, its component parts and their connections, Papez, J. W. (E.), 555
[email protected],A., “¿On
the State ofLunacy― 1859-1959, 879
W@isi-i,G. P., WALTON,
D., and BLACK,D. A., The relative efficacyof “¿Vespral―
and chlor
promazine in the treatment of a group of chronic schizophrenic patients, 199
W@@.LToN,D., A children's
,,
and
apperception
BLACK,
D.
A.,
test,
The
359
predictive
validity
of
a
psychological
test
of
brain
and
chlor
damage, 807
,,
BLACK,
D.
A.,
and
W@si@,
G.
P.,
The
relative
efficacy
of
“¿Vespral―
promazine in the treatment ofa group ofchronic schizophrenic patients, 199
,,
MATHER,
M.,
and
BLACK,
D.
A.,
The
validity
of
the
Meehl
M.M.P.I.
psychotic
scale in the diagnosis of schizophrenia, 869
W@mnaALL, M., et a!., Potentiation by phenobarbitone of effects of ethyl alcohol on human
behaviour, 51
WECKOWICZ,T. E., and BLEWETF D. B., Size constancy
and abstract thinking in schizophrenic
patients, 909
WitmE, M., and MCREYNOLDS,P., The prediction and assessment of psychological changes
following prefrontal lobotomy, 971
WEINTRAUB,
W.,
BitaiiNo,
J. R., and
on the LSD psychosis, 1095
WHEELER, A. P., FLEISCHHACKER,
KLEE, G. D.,
H. H., and
Effects
of certain
LANCASTER, J. B., Studies
vitamins
and
histamines
in schizophrenia—V.
Disturbances of protein and tryptophan metabolism and toxicity of urine, 313
Wmm, J. M., and HAMILTON,M., Clinical syndromes in depressive states, 985
Wmmi@w, E. M., FLEMING,B. G., and SPENCER,A. M., A controlled comparative investi
gation ofthe effects ofpromazine, chlorpromazine and a placebo in chronicpsychotics, 349
WHITELEY,
J. S., GRADWELL,
B. G.,
and
MAY, A. R.,
Trifluoperazine
(Stelazine)
in psycho
neuroses, 1059
Wa.u@Ms,C. E., Ba@ioN, M. W. G., and KIRMAN,B. H., Microcephaly, 721
Wilson's disease and ceruloplasmin. (E.), 568
WOODS,
D. P., a
a!.,
Potentiation
by phenobarbitone
of effects
of ethyl
alcohol
on human
behaviour, 51
W@r'm@n,
R., et a!., A comparison of the psychological effects of acute and chronic adminis
tration of chlorpromazine and secobarbital in schizophrenic patients, 190
1140
INDEX
PART 11.—AUTHORSREFERRED TO IN THE EPITOME
Aird, R. B., 533
Aprison, M., H., 557
Ashby, W., 569
Bental, E., 572
Bogoch, S., 525
Bradley, P. B., 531
Bravo, G. J., 572
Burgemeister,
B. B., 573
Buscaino, G. A., 524
Carpenter, M. B., 541
Cooper, I. S., 572
Costa, E., 557
Crosby, E. C., 571
Curran, G. L., 525
Daly, D., 569
Danziger, L., 530
Dement, W., 530
Denber, H. C. B., 520
Denny-Brown, D., 555
Denst, J., 563
Di Mascio,
A.,520
Dunlop, C. W., 533
Edisen, C. B., 526
Ellingson, R. J., 530
Ellington, R. J., 531
Esquibel, A. J., 559
Feinblatt,
T. M., 530, 554
Feld, M., 556
Ferraro,A.,
561
Fisher,
C. M., 570
Flataker, L., 526
Fraser,
H. F., 575
Friedhoff, A. J., 560
Frohman, C. E., 524
Frost,
L.L.,571
Gal,P., 519
Ganado,W.,57l
Garoutte, B., 533
Hall, R., 558
Halpern, L., 572
Hollander, L., 526
Papez, J. W., 555
Parsons, 0. A., 554
Pechtel, C., 556
Penfield, W., 522
Persky, H., 522
Petersen, P. B., 531
Poser, C. M., 525, 531
Regan, P. F., 560
Reilly, J., 560
Rinaldi, F., 557
Robertson, J. P. S., 550
Rudy, L. H., 557
Hope,J.M.,559
Hutt, P. J., 522
Key, B. J., 531
King, F. A., 555
Klee, G. D., 526
Kleitman, N., 530
Kling, A., 522
Samuels, A. S., 526
Scharenberg, K., 562
Scheinberg, I. H., 568
Showers, M. J. C., 571
Silverstein, A. B., 526
Spiegel, E. A., 573
Stefanachi, L., 524
Swank, R. L., 571
Lauer, J. W., 524
Lennox, M. A., 531
Liebert, R. S., 522
Tanck, R. H., 558
MacLean, P. D., 560
Mahrer, P. R., 520
McGeer, E. G., 554
Victor, M., 559
McGeer, P. L., 554
Masserman, J. H., 518
Mimer, B., 522
Miyazaki,M., 556
Monroe, R. R., 530
Truitt, E. B., jr., 556
Weckowicz,
T. E., 558
Winter, C. A., 526
Wood, C. D., 571
Zimmerman,F.T.,573